Skip to content
Disclosery

Exome Asset Management LLC

Follow

13F filer, CIK 2011932, NEW YORK, NY

Exome Asset Management LLC reported $112,495,086 across 59 holdings for the quarter ended 2025-03-31, in a 13F-HR/A filed 2025-05-16. Its ten largest share positions make up 39.5% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001420506-25-001316

Period
2025-03-31
Reported value
$112M
Holdings
59
Top 10 weight
39.5%
New
25
Sold out
25

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AZNnew+32,534$4.73M
COGTnew+621,678$3.72M
VRDNnew+217,294$2.93M
RGNXnew+405,281$2.9M
DYNnew+258,391$2.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
HUMexited-18,066-$4.58M
RLAYexited-1,083,487-$4.46M
APLSexited-119,467-$3.81M
BMYexited-65,200-$3.69M
BSXexited-40,500-$3.62M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR/A 0001420506-25-001316, largest first. % of portfolio is the value over $111,647,026, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 211,000 shares; 2024Q4: 246,700 shares; 2025Q1: 165,496 shares 165,496$5.72M5.12%-81,204Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 89,800 shares; 2024Q4: 147,800 shares; 2025Q1: 127,182 shares 127,182$5.42M4.85%-20,618Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 905,126 shares; 2024Q4: 1,561,152 shares; 2025Q1: 3,215,457 shares 3,215,457$5.11M4.58%+1,654,305Timeline
AZNASTRAZENECA PLC-SPONS ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 32,534 shares 32,534$4.73M4.23%newTimeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 58,583 shares; 2024Q4: 65,883 shares; 2025Q1: 103,483 shares 103,483$4.16M3.73%+37,600Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 318,900 shares; 2025Q1: 337,198 shares 337,198$4.14M3.71%+18,298Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 61,367 shares; 2025Q1: 135,616 shares 135,616$4.09M3.66%+74,249Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,447 shares; 2024Q4: 8,247 shares; 2025Q1: 4,673 shares 4,673$3.86M3.46%-3,574Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 621,678 shares 621,678$3.72M3.34%newTimeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,427 shares; 2024Q4: 7,427 shares; 2025Q1: 6,358 shares 6,358$3.15M2.82%-1,069Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 77,285 shares; 2025Q1: 43,441 shares 43,441$3.1M2.78%-33,844Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 77,100 shares; 2024Q4: 68,608 shares; 2025Q1: 76,379 shares 76,379$3.09M2.77%+7,771Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 64,516 shares; 2024Q4: 69,072 shares; 2025Q1: 61,656 shares 61,656$3.06M2.74%-7,416Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 174,400 shares; 2024Q4: not reported; 2025Q1: 217,294 shares 217,294$2.93M2.62%newTimeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 405,281 shares 405,281$2.9M2.6%newTimeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 54,738 shares; 2025Q1: 294,846 shares 294,846$2.87M2.57%+240,108Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 133,039 shares; 2024Q4: 77,439 shares; 2025Q1: 84,339 shares 84,339$2.71M2.43%+6,900Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 258,391 shares 258,391$2.7M2.42%newTimeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 22,450 shares; 2024Q4: 22,450 shares; 2025Q1: 18,650 shares 18,650$2.64M2.36%-3,800Timeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 300,600 shares; 2024Q4: 225,323 shares; 2025Q1: 353,882 shares 353,882$2.57M2.3%+128,559
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 9,000 shares; 2025Q1: 9,000 shares 9,000$2.41M2.16%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 699,698 shares; 2025Q1: 836,397 shares 836,397$2.32M2.08%+136,699Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 116,623 shares 116,623$2.17M1.94%newTimeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 118,017 shares 118,017$2.11M1.89%newTimeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 138,152 shares; 2024Q4: 137,716 shares; 2025Q1: 142,744 shares 142,744$2.05M1.84%+5,028Timeline
GEHCGE HEALTHCARE TECHNOLOGIES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 25,400 shares 25,400$2.05M1.84%newTimeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 283,599 shares; 2025Q1: 689,137 shares 689,137$1.98M1.78%+405,538Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 120,165 shares; 2024Q4: 151,965 shares; 2025Q1: 102,944 shares 102,944$1.78M1.6%-49,021Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 263,841 shares 263,841$1.78M1.59%newTimeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,300 shares; 2024Q4: 10,000 shares; 2025Q1: 6,500 shares 6,500$1.77M1.58%-3,500Timeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 51,295 shares 51,295$1.72M1.54%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 59,900 shares; 2024Q4: 81,473 shares; 2025Q1: 71,438 shares 71,438$1.57M1.41%-10,035Timeline
RDYDR REDDYS LABS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 36,300 shares; 2024Q4: 117,500 shares; 2025Q1: 117,500 shares 117,500$1.55M1.39%0Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 289,690 shares 289,690$1.54M1.38%newTimeline
KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,000,000 shares; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares 2,000,000$1.52M1.36%0
NEKTAR THERAPEUTICSNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 618,174 shares; 2025Q1: 2,232,453 shares 2,232,453$1.52M1.36%+1,614,279
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 218,700 shares; 2025Q1: 195,295 shares 195,295$1.37M1.23%-23,405Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 468,499 shares; 2024Q4: 1,097,999 shares; 2025Q1: 1,097,999 shares 1,097,999$1.21M1.08%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 163,738 shares 163,738$1.03M0.92%newTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 133,113 shares 133,113$982K0.88%newTimeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 28,159 shares; 2025Q1: 39,900 shares 39,900$959K0.86%+11,741Timeline
ALVOALVOTECHQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 90,100 shares; 2024Q4: 90,100 shares; 2025Q1: 90,100 shares 90,100$871K0.78%0Timeline
VYNEVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 353,434 shares; 2024Q4: 353,434 shares; 2025Q1: 462,801 shares 462,801$731K0.65%+109,367Timeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,700 shares; 2024Q4: 13,100 shares; 2025Q1: 13,100 shares 13,100$535K0.48%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 196,500 shares; 2024Q4: not reported; 2025Q1: 60,600 shares 60,600$454K0.41%newTimeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 256,373 shares; 2025Q1: 114,145 shares 114,145$387K0.35%-142,228Timeline
AKBAAKEBIA THREAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 205,956 shares; 2025Q1: 189,087 shares 189,087$363K0.33%-16,869Timeline
NUVBNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 96,311 shares 96,311$170K0.15%newTimeline
APREAPREA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 137,174 shares; 2024Q4: 127,960 shares; 2025Q1: 28,972 shares 28,972$59.1K0.05%-98,988Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
TRAVERE THERAPEUTICS INCTRAVERE THERAPEUTICS INC COMcall110,000$231Knew
ALDEYRA THERAPEUTICS INCALDEYRA THERAPEUTICS INC COMput100,000$190Knew
CYTOKINETICS INCCYTOKINETICS INC PUTput23,000$141Knew
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC CALLcall37,500$129Knew
RHYTHM PHARMACEUTICALS INCRHYTHM PHARMACEUTICALS INC COMput40,000$70Knew
GOSSAMER BIO INCGOSSAMER BIO INC COMcall100,000$47.5Knew
NEKTAR THERAPEUTICS CMN STKNEKTAR THERAPEUTICS CMN STK Cmncall75,000$22.5Knew
ROIVANT SCIENCES LTDROIVANT SCIENCES LTD SHSput75,300$15.1Knew
VERU INCVERU INC COMcall60,000$900new
SOLENO THERAPEUTICS INCSOLENO THERAPEUTICS INC PUTput11,000$275new

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
HUMHUMANA INC18,066$4.58Mshares
RLAYRELAY THERAPEUTICS INC1,083,487$4.46Mshares
APLSAPELLIS PHARMACEUTICALS INC119,467$3.81Mshares
BMYBRISTOL-MYERS SQUIBB CO65,200$3.69Mshares
BSXBOSTON SCIENTIFIC CORP40,500$3.62Mshares
NUVLNUVALENT INC40,580$3.19Mshares
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORP31,800$2.77Mshares
GILDGILEAD SCIENCES INC29,700$2.74Mshares
SMMTSUMMIT THERAPEUTICS INC130,412$2.33Mshares
JANXJANUX THERAPEUTICS INC40,123$2.15Mshares
RCKTROCKET PHARMACEUTICALS INC159,552$2.01Mshares
TARSTARSUS PHARMACEUTICALS INC28,178$1.56Mshares
PLRXPLIANT THERAPEUTICS INC103,504$1.36Mshares
STOKSTOKE THERAPEUTICS INC113,096$1.25Mshares
LEGNLEGEND BIOTECH CORP37,600$1.22Mshares
TECXTECTONIC THERAPEUTIC INC26,081$1.2Mshares
ACRSACLARIS THERAPEUTICS INC389,333$966Kshares
ANNXANNEXON INC144,830$743Kshares
Veru IncVeru Inc1,117,600$740Kshares
ACELYRIN INCACELYRIN INC234,435$736Kshares
MDGLMADRIGAL PHARMACEUTICALS INC987$305Kshares
CYPHCYPHERPUNK TECHNOLOGIES INC102,631$295Kshares
Mersana Therapeutics IncMersana Therapeutics Inc172,924$250Kshares
NEUMORA THERAPEUTICS INC.NEUMORA THERAPEUTICS INC.600$207Kcall
ABUSARBUTUS BIOPHARMA CORP28,300$92.5Kshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-001281 superseded2025-05-15acceptance time not in the bulk data set
13F-HR/A 0001420506-25-001316 baserestatement2025-05-16acceptance time not in the bulk data set